GHK-Cu Dosing Protocol — Topical Concentrations, Subcutaneous Ranges, and Vial Math

GHK-Cu — glycyl-L-histidyl-L-lysine bound to copper(II) — is the most-studied tripeptide in dermatological research, and the dose record is unusually well-documented thanks to four decades of Loren Pickart's lab work. The catch: published doses span three orders of magnitude, because topical, subcutaneous, and in-vitro use cases all use different math. This guide separates the three, walks the 50 mg / 100 mg vial reconstitution, and frames it for UAE peptide researchers ordering through REVIVE LAB.

1. Why GHK-Cu dosing splits three ways

GHK is a naturally occurring tripeptide in human plasma. Concentrations drop from ~200 ng/mL in a 20-year-old to ~80 ng/mL by age 60 — a roughly 60% decline that maps loosely to the visible markers of skin and wound-healing slowdown. Pickart's central finding (Pickart 2008, Pickart 2018) is that GHK only works when it's chelated to copper(II); the free tripeptide doesn't do the gene-expression work. That's why suppliers ship the blue-tinted copper-bound form, not the colourless peptide.

The dosing literature splits because the three delivery routes are answering three different research questions:

• Topical: what concentration in a cream or serum produces fibroblast activation in skin biopsy?
• Subcutaneous: what systemic dose drives wound-healing acceleration or hair-follicle effects in animal models?
• In vitro: what micromolar concentration changes gene expression in cell culture? (Not directly useful for in-vivo dose math.)

2. Topical GHK-Cu — the Pickart-derived concentration range

The dermatology research literature has converged on a topical concentration window of 0.05% to 0.2% for face/skin applications. That's 500 to 2,000 parts per million, or 0.5 to 2 mg of GHK-Cu per gram of vehicle. Above 0.2%, fibroblast activation curves flatten — the receptor system saturates and further peptide adds cost without benefit.

Practical formulation math: 100 mg of GHK-Cu dissolved into 50 g of base cream produces 0.2%. 100 mg into 100 g produces 0.1%. The peptide is water-soluble; standard practice is to dissolve in a small volume of sterile or bacteriostatic water first, then blend into the carrier. UV exposure and prolonged warm storage degrade copper-tripeptide complexes — store finished formulations refrigerated and use within 60-90 days.

3. Subcutaneous GHK-Cu — the dose range published in wound and hair research

Published rat and rabbit studies (Pickart and Lovejoy, Maquart et al.) used SC dose ranges of 1-3 mg/kg in rodent models for wound healing and fur regrowth. Allometric scaling from rodent to human-equivalent dose using the FDA conversion factor (rat: divide by 6.2) gives a research-equivalent dose range of roughly 0.16-0.48 mg/kg — for a 70 kg adult researcher dose calculation, that's 11-34 mg per dose.

However, most current research protocols in human-orientated work cite a lower daily dose of 1-2 mg subcutaneous per day, often divided across multiple sites. This is below allometric scaling — researchers favour a lower dose because the copper component carries a non-trivial risk profile at higher systemic exposure, and observable endpoints (improved skin tone, hair-shaft thickening) are reported in the 1-3 mg/day window without escalating to higher doses.

4. The 50 mg vs 100 mg vial decision

REVIVE LAB UAE stocks GHK-Cu in two vial sizes — 50 mg and 100 mg. The choice between them is mostly a logistics question, not a biology question:

For researchers running a single 4-week SC course at 2 mg/day, total exposure is 56 mg — meaning either two 50 mg vials or one 100 mg vial with leftover. For topical formulation work where peptide dissolves into multi-gram batches of base cream, the 100 mg vial is invariably more efficient.

5. Storage — copper-tripeptide stability

The copper-bound tripeptide is more thermally stable than its uncomplexed form but less stable than glycine-based simple peptides. The Pickart literature documents stability up to roughly 60 °C for short windows in solution, dropping rapidly above that. Practical storage guidance for the UAE context:

• Lyophilised vials: 24+ months refrigerated at 2-8 °C. Tolerates room-temperature shipping windows of 24-48 hours.
• Reconstituted in bac water: 28 days refrigerated. The peptide retains its characteristic blue tint when copper-chelation is intact — fading to clear or yellow indicates degradation.
• Topical formulations: 60-90 days refrigerated in opaque packaging. Sunlight and warm storage accelerate degradation.
• Freezer: Possible but freeze-thaw cycles damage the copper-peptide bond — single thaw only.

UAE summer ambient routinely hits 45 °C, which is above the safe handling envelope for reconstituted peptide. REVIVE LAB ships in insulated packaging with cold-pack inserts year-round. See UAE peptide cold-chain shipping for the full thermal-stability decision matrix.

6. The hair regrowth question

Published hair-follicle research on GHK-Cu shows fibroblast growth factor upregulation and reduced apoptosis of dermal papilla cells (Pickart and Margolina 2012, Pyo et al. 2007). Most published hair-protocol research uses topical application at 0.1-0.2% directly to the scalp, often combined with mild barrier disruption (microneedling at 0.5-1.0 mm depth) to improve follicle delivery. SC dosing for hair-orientated research is uncommon in the literature — local delivery dominates the published protocols. The full evidence map sits in our dedicated post on GHK-Cu hair regrowth research.

7. UAE supply context

UAE peptide researchers asking about GHK-Cu have a specific supply concern: the copper-chelated form is the active form, and grey-market suppliers sometimes ship uncomplexed GHK as "GHK-Cu" to cut cost. REVIVE LAB UAE supplies copper-chelated GHK-Cu — the lyophilised powder has the characteristic blue-tint that becomes obvious on reconstitution. Lot-level HPLC certificate of analysis confirms peptide identity and copper content on every batch.

Both vial sizes are stocked: GHK-Cu UAE ships from Dubai same-day on orders before 3 PM, 24 hours to Dubai/Abu Dhabi/Sharjah/Ajman, 24-48 hours to Al Ain/RAK/Fujairah. Cash on delivery available; HPLC COA in every parcel.

8. The summary

• Topical research formulations: 0.05-0.2% (500-2000 ppm). Above 0.2%, returns flatten.
• SC research dose range in modern protocols: 1-3 mg/day, with 1-2 mg the most common cited window.
• 50 mg + 2 mL bac water = 25 mg/mL (8 U-100 units for 2 mg). 100 mg + 2 mL = 50 mg/mL (4 units for 2 mg).
• Refrigerate reconstituted vials at 2-8 °C; the blue copper-tint should remain throughout the storage life.
• Available as GHK-Cu UAE via REVIVE LAB in HPLC-verified 50 mg and 100 mg vials with lot-level COA.